Here, we show that ANXA2 is significantly over-expressed in GBM in three independent cohorts of patients (Figure 1A–1D) and that ANXA2 expression can be considered as an independent prognostic factor in glioma [31, 47–49]. The gene discussed is ANXA2; the disease is glioma.